ARCHIVES

Tykerb And Trastuzumab Showed Increase In PFS For HER2+ Breast Cancer In Study

This article is from The Cancer Letter archive.

Vol. 31 No. 5 | May 30, 2008

Download PDF Visit The Full Archive

Related Articles

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

Nutrition Research Priority Areas Outlined By NCI

December 6, 1974

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

Tempero, Johnson To Lead ASCO

March 28, 2003

New Grant Program in Physical Activity

March 28, 2003

New Genetic Test Approved For Breast Cancer Patients

July 25, 2008